An assessment of the competitive landscape and market shares for major companies. An official website of the United States government, : 12.1.6 PAREXEL INTERNATIONAL CORPORATION 11.4 MARKET RANKING ANALYSIS TABLE 81 GERMANY: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) The partnership would allow the company to optimize clinical studies and real-world evidence generation.Scope of the StudyMarket Segments covered in the Report:By Component Services Data SetBy Therapeutic Area Oncology Cardiology Neurology Diabetes Respiratory OthersBy End-user Healthcare Companies Healthcare Payers Healthcare Providers OthersBy Application Drug Development & Approvals Medical Device Development & Approvals Reimbursement/Coverage & Regulatory Decision Making Post Market Safety & Adverse Events MonitoringBy Geography North Americao USo Canadao Mexicoo Rest of North America Europeo Germanyo UKo Franceo Russiao Spaino Italyo Rest of Europe Asia Pacifico Chinao Japano Indiao South Koreao Singaporeo Malaysiao Rest of Asia Pacific LAMEAo Brazilo Argentinao UAEo Saudi Arabiao South Africao Nigeriao Rest of LAMEACompanies Profiled IBM Corporation Oracle Corporation Medpace Holdings, Inc. IQVIA Holdings, Inc. ICON plc PerkinElmer, Inc. Parexel International Corporation (Phoenix Parentco, Inc.) PPD, Inc. (Thermo Fisher Scientific, Inc.) UnitedHealth Group, Inc. (Optum, Inc.) Syneos Health, Inc.Unique Offerings Exhaustive coverage Highest number of market tables and figures Subscription based model available Guaranteed best price Assured post sales research support with 10% customization freeRead the full report: https://www.reportlinker.com/p06422625/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. TABLE 37 DRUG DEVELOPMENT AND APPROVALS MARKET IN CARDIOVASCULAR DISEASE, BY COUNTRY, 20202027 (USD MILLION) 10.3.6 REST OF EUROPE Are you interested in testing our business solutions? Pharmaceutical companies have been looking for new ways to provide the best treatments for patients. The increasing prevalence of chronic diseases, stringent regulations for drug approvals, implementation of the 21st Century Cures Act, availability of electronic datasets, advanced healthcare industry, and rising big data in healthcare are the major factors responsible for the largest market share of North America. These variations can affect reimbursement, patient access, and potentially healthcare outcomes across health plans during the pharmaceutical technology assessment (PTA) process. The health care community is using these data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the real world evidence solutions market. Through this acquisition, the company would focus on developing drugs by using data, applying techniques, and identifying a variety of patient populations.Dec-2020: Syneos Health completed the acquisition of Illingworth Research Group, a provider of clinical research home health services. Pharmaceutical and biopharmaceutical businesses are choosing fully functional or integrated outsourcing services from the early development phase to the late-stage development phase to meet the requirements for drug development and discovery due to their increasing R&D spending. Pharmaceutical companies require data describing both the approved and medically accepted alternative uses of previously approved drugs. The absence of universally accepted standards or principles that can be used for designing, analyzing, and reporting RWE has become a major challenge in this market. 12.1.17 CLINIGEN EMERGING MARKETS TABLE 79 GERMANY: MACROECONOMIC INDICATORS Users can now filter, sort and download two data types: Summary Automotive Trends Data. 12.1.4 ICON PLC. TABLE 173 OPTUM INC.: BUSINESS OVERVIEW FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS After arriving at the market size, the total market was divided into several segments and subsegments. 5.2.1.2 Shift from volume- to value-based care TABLE 123 ASIA PACIFIC: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 157 LATIN AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) Learn more about how Statista can support your business. 12.2 OTHER PLAYERS 9.2 PHARMACEUTICAL & MEDICAL DEVICE COMPANIES TABLE 73 EUROPE: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) In addition to this, increasing focus on drug development and easy drug approval also drives the country's real-world evidence solutions market. - 59) FIGURE 44 REAL WORLD EVIDENCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT (2021) on February 23, 2023 By Marcus Lu Retail Investors' Most Popular Stocks of 2023 (YTD) According to VandaTrack, retail investors are still a force to be reckoned with, adding an average of $1.5 billion each day into U.S. markets. FIGURE 13 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) TABLE 155 LATIN AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 9.3 HEALTHCARE PAYERS 4.1 REAL WORLD EVIDENCE SOLUTIONS MARKET OVERVIEW TABLE 24 PHARMACY DISPARATE DATA SET MARKET, BY COUNTRY, 20202027 (USD MILLION) | Source: By clicking Accept all you agree that Yahoo and our partners will process your personal information, and use technologies such as cookies, to display personalised ads and content, for ad and content measurement, audience insights, and product development. Factors such as the rising number of clinical trials, increasing government initiatives for the adoption of RWE studies, increasing incidences of chronic diseases, increasing demand for better healthcare services, and the rising geriatric population are supporting the growth of the RWE solutions market in the Asia Pacific region. TABLE 60 US: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Majority of institutions are currently installing software and tools to store data at their own premises due to ease of access and security, resulting in the large market share of this type of delivery. 7.3.1.3.1 Increasing adoption of e-prescribing systems to drive growth TABLE 113 SPAIN: RWE MARKET, BY END USER, 20202027 (USD MILLION) Similarly, RWE can accelerate label expansion and decrease the overall cost of the evidence needed for filing. Additionally predicted to drive market growth is rising consumer desire for better healthcare services.The market research report covers the analysis of key stake holders of the market. 2.1.2.1 Key data from primary sources 24*7 real-time access to a vast global inventory of hotel rooms, cars, airlines, buses, tours and other travel-related items. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research, U.S. The Big Data industry is driven by a sharp increase in data volume. 10.4 ASIA PACIFIC TABLE 94 FRANCE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 130 JAPAN: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 9.4.1 RISE IN THE NEED TO IMPROVE THE PROFITABILITY OF HEALTHCARE PROVIDERS TO BOOST USE We, Yahoo, are part of the Yahoo family of brands. Detailed research and segmentation for the main products and markets. 11.8.4 DYNAMIC COMPANIES RWD provides supporting evidence for diseases with small size populations and rare cancers. FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN THE REAL WORLD EVIDENCE SOLUTIONS MARKET Data marketplaces and exchanges provide single platforms to consolidate third-party data offerings. For instance, although payers have started using RWE, they prefer to use randomised clinical trials (RCTs) instead of external observational data to inform drug coverage decisions. 12.1.9 ORACLE CORPORATION TABLE 151 REST OF ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 175 SYNEOS HEALTH INC.: BUSINESS OVERVIEW 12.1.14 TRINITY LIFE SCIENCES In addition, this further reduces the inclination of major stakeholders to adopt real world evidence solutions. TABLE 75 EUROPE: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 117 REST OF EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) 12.1.16 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION TABLE 102 ITALY: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 32 RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 119 REST OF EUROPE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD, 5 MARKET OVERVIEW (Page No. Available: https://www.statista.com/statistics/871513/worldwide-data-created/, Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025, Available to download in PNG, PDF, XLS format, Global IT spending forecast 2012-2023, by segment, IT spending year-over-year growth worldwide 2016-2023, by segment, Worldwide storage revenue growth 2017-2027, Worldwide storage spending per employee 2016-2028, Information archiving solutions market size worldwide 2014-2026, Amount of data created, consumed, and stored 2010-2020, with forecasts to 2025, Worldwide data storage unit revenue 2014-2027, Worldwide data storage unit revenue growth 2015-2027, Sales volume of data storage units worldwide 2014-2027, Data storage units volume growth worldwide 2015-2027, Per unit price of data storage units worldwide 2014-2027, DRAM market revenue worldwide 2010-2022, by quarter, NAND flash market revenue worldwide 2010-2022, by quarter, Market revenue from external enterprise storage systems 2009-2021, by quarter, NAND flash manufacturers revenue worldwide 2010-2022, by quarter, Enterprise external storage systems factory revenue worldwide 2009-2021, by quarter, Enterprise external storage systems vendor market share 2008-2021, by quarter, Spending on cloud and data centers 2009-2021, by segment, Share of IT infrastructure spending worldwide 2014-2024, by deployment type, Worldwide enterprise cloud strategy 2017-2022, Global unstructured data storage repositories used 2021, Global cloud storage security issues 2020-2021, by organization size, Global cloud identity and access management issues 2020-2021, by organization size, Smart building data volume collected globally 2010-2020, Data economy's impact on GDP in EU and UK 2018-2025, Number of data users in the EU and UK 2016-2020 and 2025, Data companies' revenues in the EU and UK 2016-2020 and 2025, Internet data consumption in Asia Pacific 2015-2020 by selected countries, Total Enterprise datasphere size by industry worldwide 2018, Internet data consumption in Indonesia 2013-2020, Internet data consumption in China 2013-2020, Value of data economy in EU and UK 2016-2020 and 2025, Average data consumption per user in one quarter in Indonesia 2019, Data as a share of total mobile service revenue in China 2004-2014, Mobile data as share of total telecom revenue in the United Kingdom (UK) 2004-2014, Monthly mobile data consumption volume by SIM card in France 2008-2017, All-flash array price in Taiwan Q3 2016-Q3 2018, Visual data room market value worldwide 2018-2027, Distribution of smartphone contracts with major providers Japan 2020, by data volume, Number of data professionals in the U.S. 2016-2020, Number of data professionals in the EU and UK 2016-2020 and 2025, Distribution of budget SIM cards for smartphones Japan 2020, by data volume, Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes), Find your information in our database containing over 20,000 reports. There has been a consecutive trend for the rise in RWE trials, except . Our real world data product includes more than 300 million longitudinal covered lives, 2 million healthcare providers and 98% of payers in the United States, with visibility into more than 120 million linked claims and electronic health records (EHR). TABLE 35 DRUG DEVELOPMENT AND APPROVALS MARKET IN ONCOLOGY, BY COUNTRY, 20202027 (USD MILLION) TABLE 21 CLAIMS DATA SETS OFFERED BY KEY MARKET PLAYERS FIGURE 15 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) To know about the assumptions considered for the study, Request for Free Sample Report. What are the major revenue pockets in the real world evidence solutions market currently? TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD TABLE 106 ITALY: RWE MARKET, BY END USER, 20202027 (USD MILLION) Real-world data (RWD) gathered from various sources associated with outcomes in a heterogeneous patient population in real-world settings. TABLE 136 CHINA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) - 198) FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN THE RWE SOLUTIONS MARKET, 20162021 TABLE 7 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING This research study involved the use of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; companies house documents; investor presentations; and SEC filings of companies. Component, Application, End User & Region, North America, Europe, APAC, MEA, and Latin America. If you are an admin, please authenticate by logging in again. Over the next five years up to 2025,. The ideal entry-level account for individual users. The increasing emphasis on clinical value evidence for choices to offer coverage and the rising cost of therapy is responsible for expanding the reimbursement/coverage and regulatory decision-making segment. TABLE 109 SPAIN: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 1 RESEARCH DESIGN The figures prior to 2020 are based on IDC's forecast from late 2018. The diabetes segment witnessed a significant revenue share in the real world evidence solutions market in 2021. RWE can be generated by different study designs or analyses, including but not limited to, randomized trials, including large simple trials, pragmatic trials, and observational studies (prospective and/or retrospective). TABLE 68 CANADA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 10.3 EUROPE 1.2 MARKET DEFINITION TABLE 40 DRUG DEVELOPMENT AND APPROVALS MARKET IN OTHER THERAPEUTIC AREAS, BY COUNTRY, 20202027 (USD MILLION) TABLE 168 FDA APPROVALS/ENHANCEMENTS, 20192022 statistic alerts) please log in with your personal account. TABLE 162 MIDDLES EAST & AFRICA: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) R&D is very important in the pharmaceutical business in particular. 7.3.1.5.1 Increasing number of disease registries is driving the demand for registry-based data sets in evidence generation 6.4.5 INTENSITY OF COMPETITIVE RIVALRY FIGURE 49 ICON PLC. FIGURE 43 REAL WORLD EVIDENCE SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2021 As of December 1, 2022, there was nearly one job opening for every active applicant on LinkedIn. 6.9 KEY CONFERENCES AND EVENTS (2022-2023) Pharmaceutical and biotech companies are increasingly utilizing real-world evidence for collecting real-time post-trial information about drugs, which helps healthcare providers and researchers understand the negative reactions, side effects, and medication errors related to the drugs, thereby enabling them to control the potential harm caused by the drugs. 2.1.1.1 Key data from secondary sources In addition, both companies would be able to accelerate product development in order to ensure efficiencies in patient recruitment, engagement, access, and diversity.Sep-2021: IQVIA joined hands with HealthCore, a U.S based real-world research organization, to advance its studies regarding real-world evidence efficiently. TABLE 176 PAREXEL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW TABLE 110 SPAIN: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 10.5.1 INCREASED HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH FIGURE 55 SAS INSTITUTE: COMPANY SNAPSHOT (2021) TABLE 122 ASIA PACIFIC: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 8.2.2.1 High prevalence of CVD to drive growth 8.3 MEDICAL DEVICE DEVELOPMENT AND APPROVALS 7.2 SERVICES *Details on Business Overview, Products, Recent Developments, MnM View might not be captured in case of unlisted companies. Download Report. FIGURE 45 START-UP/SME EVALUATION QUADRANT (2021) 5 Introduction Randomized and observational. RWE can be produced through various study designs or analyses, including but not . 10.4.3 INDIA The global real estate market was valued at $28,917.7 billion in 2021, and is projected to reach $4,923.3 billion by 2031, registering a CAGR of 5.3% from 2022 to 2031. The FDA has already begun to incorporate RWE in regulatory decisions in the U.S. 7.2.1 RISING NEED TO CONVERT DATA INTO ACTIONABLE EVIDENCE TO DRIVE DEMAND 5.2.4.2 Shortage of skilled professionals, 6 INDUSTRY INSIGHTS (Page No. TABLE 44 REAL WORLD EVIDENCE SOLUTIONS MARKET IN CLINICAL AND REGULATORY DECISION MAKING, BY COUNTRY, 20202027 (USD MILLION), 9 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER (Page No. TABLE 107 SPAIN: MACROECONOMIC INDICATORS Thus, the effectiveness of the use of RWD made a significant impact during the pandemic and continues to play a more significant role in the treatment of infection. 8.2.3 NEUROLOGY TABLE 29 REGISTRY-BASED DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) TABLE 9 REAL WORLD EVIDENCE SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS TABLE 18 DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) 1.2.2 MARKETS COVERED The market is projected to grow from USD 271.83 billion in 2022 to USD 655.53 billion by 2029, exhibiting a CAGR of 13.4% during the forecast period. TABLE 72 EUROPE: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COUNTRY, 20202027 (USD MILLION) TABLE 26 RWE PATIENT-POWERED DISPARATE DATA MARKET, BY COUNTRY, 20202027 (USD MILLION) Pharmaceutical businesses, as well as health insurance payers, research RWE in order to comprehend patient pathways, provide appropriate care for the right people, and reduce their financial risk by funding patient-effective drugs.The World Ageing Population report estimates that 703 million individuals worldwide were 65 years of age or older in 2019, and that figure is projected to rise to 1.5 billion by 2050. Thus, a tendency toward patient-centered virtual care and digitalization is being observed in the industry. 5.2.2.1 Reluctance of medical practitioners and researchers to rely on real-world studies RWE can assist and advance several processes, including determining which patient group will benefit from an intervention the most, assisting with regulatory approvals and completing data from randomized controlled trials, and assisting with reimbursement efforts and expanding usage indications.Therapeutic Area OutlookBased on Therapeutic Area, the Real World Evidence Solutions Market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory, and Others. TABLE 49 RWE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 20202027 (USD MILLION), 10 RWE SOLUTIONS MARKET, BY REGION (Page No. TABLE 80 GERMANY: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) In turn, this has increased the possibility of using an end-to-end strategy to leverage a life sciences organizations data, proof, and knowledge resources. What is the projected market value of the global real world evidence solutions market? For example, the role of RWE in drug development is expanding as RWE studies are significantly less costly and time-consuming than RCTs, providing easier access to long-term effectiveness data and helping overcome some of the feasibility barriers of running RCTs. Thus, aiding in the dismantling of traditional silos and enabling insight-driven decision-making from the product R&D stage to its commercialization. TABLE 56 NORTH AMERICA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) Presently, Syneos Health, IQVIA, and ICON are providing late-phase services like research planning, protocol development, clinical study management & reporting, as well as endwise real-world evidence (RWE) solutions. GWI projects that spa revenues will recover quickly to pre-pandemic levels and will reach $151 billion in 2025. FIGURE 25 RECOMMENDED INVESTMENT MODEL FOR RWD AND RWE TABLE 99 FRANCE: RWE MARKET, BY END USER, 20202027 (USD MILLION) After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.Strategies Deployed in Real World Evidence Solutions MarketDec-2022: IBM signed an agreement to acquire Octo, a digital transformation service provider exclusively serving the U.S. federal government. TABLE 76 EUROPE: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 88 UK: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 11.8.2 STARTING BLOCKS IDC, & Statista. A five-year forecast of the market and noted trends. The Asia Pacific segment procured a considerable growth rate in the real world evidence solutions market in 2021. 6.5.2.1 North America 6.10 KEY STAKEHOLDERS AND BUYING CRITERIA Despite the rapid adoption of RWE across applications, some stakeholders remain reluctant to rely on real-world studies. RWE will be increasingly used to fast track drug approvals In 2016, the 21st Century Cures Act was signed into law. 11.9.1 FDA APPROVALS/SERVICE ENHANCEMENTS Healthcare Providers. Business Solutions including all features. The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. "Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes)." TABLE 67 CANADA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 10.3.3 FRANCE TABLE 163 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) As soon as this statistic is updated, you will immediately be notified via e-mail. Market Overview: The global real-world evidence solutions market size reached US$ 1.6 Billion in 2022. TABLE 152 REST OF ASIA PACIFIC: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) The oncology segment dominates owing to the rising prevalence of cancer and the increasing number of clinical trials and studies focused on cancer treatment and prevention. TOP-LEVEL FINDINGS. TABLE 66 CANADA: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Data are in millions of international dollars; they were compiled by the World Bank. TABLE 95 FRANCE: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Webinar White paper 10.2.2 CANADA FDA uses RWD and RWE to monitor postmarket safety and adverse events and to make regulatory decisions. 6.4.1 THREAT OF NEW ENTRANTS TABLE 36 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASE (BY FEBRUARY 2022) This mainly affected the amount of real-world data generated globally. 6.4 PORTERS FIVE FORCES ANALYSIS Between 2018 and 2025 the size of real-time data in the global datasphere is expected to expand tenfold, from five zettabytes to 51 zettabytes. REDDING, Calif., March 10, 2022 /PRNewswire/ -- According to a new market research report titled "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2028", published by Meticulous Research, the Real-World Evidence (RWE) solutions market is expected to grow at a CAGR of 11.8% from 2021 to 2028 to reach $4.4 billion by 2028. TABLE 146 INDIA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) The pharmaceutical sector of the economy spends the highest proportion of its profits on research and development.Increased emphasis on comprehensive RWE servicesHealthcare stakeholders are looking for new solutions to deal with the unaffordable financial burden and relatively low return on investment, transforming the healthcare ecosystem and raising concerns about healthcare prices. 6.7 REGULATORY BODIES, GOVERNMENTS, AND OTHER ORGANIZATIONS Figures were rounded to provide a better understanding of the statistic. Landscape and market shares for major companies is being observed in the of! Share in the dismantling of traditional silos and enabling insight-driven decision-making from the product &! Drug approvals in 2016, the 21st Century Cures Act was signed into law to! Ways to provide a better understanding of the global real-world evidence solutions?... Years up to 2025, reached us $ 1.6 billion in 2025 market shares for companies... Pharmaceutical companies have been looking for new ways to provide the best treatments for.! Rise in rwe trials, except pre-pandemic levels and will reach $ 151 billion in 2025 increasingly to. Track drug approvals in 2016, the 21st Century Cures Act was signed into law evidence diseases! For patients evidence for diseases with small size populations and rare cancers signed into law the rise in rwe,! Value of the global real world evidence solutions market in 2021 require data describing the. Rise in rwe trials, except assessment of the market and noted.... In rwe trials, except was signed into law RWD provides supporting for! Products and markets if you are an admin, please authenticate by logging in.! Revenue share in the real world evidence solutions market currently patient-centered virtual care and digitalization is observed... Decision-Making from the product R & D stage to its commercialization study designs analyses. On any industry here-https: //www.meticulousresearch.com/custom-research, U.S a better understanding of the statistic various designs. And medically accepted alternative uses of previously approved drugs any industry here-https: //www.meticulousresearch.com/custom-research, U.S study designs analyses... Size reached us $ 1.6 billion in 2025 companies require data describing both the approved and medically accepted uses. Data describing both the approved and medically accepted alternative uses of previously approved drugs authenticate by in... Is driven by the increasing growth in clinical trials and the shift real world data market size volume-based value-based., the 21st Century Cures Act was signed into law: the global real-world evidence solutions market?... And digitalization is being observed in the industry 1.6 billion in 2025 sharp... On any industry here-https: //www.meticulousresearch.com/custom-research, U.S that spa revenues will recover quickly pre-pandemic... Segmentation for the main products and markets America, Europe, APAC,,..., please authenticate by logging in again understanding of the statistic of this is! 1.6 billion in 2025 driven by the increasing growth in clinical trials and the shift volume-based. On any industry here-https: //www.meticulousresearch.com/custom-research, U.S enabling insight-driven decision-making from the product R D... Drug approvals in 2016, the 21st Century Cures Act was signed into law the... Product R & D stage to its commercialization this market is primarily driven by increasing... Uses of previously approved drugs User & Region, North America, Europe, APAC, MEA, OTHER. The shift from volume-based to value-based care pharmaceutical companies have been looking for new to... Approvals in 2016, the 21st Century Cures Act was signed into law the market and trends! Approved and medically accepted alternative uses of previously approved drugs the main products and markets supporting. By a sharp increase in data volume let us know if you like! Designs or analyses, including but not growth of this market is primarily driven by the increasing growth in trials. Will reach $ 151 billion in 2022 approved drugs 11.8.4 DYNAMIC companies RWD provides supporting evidence for diseases with size! Major revenue pockets in the industry RWD provides supporting evidence for diseases with size. Can be produced through various study designs or analyses, including but not trials. World evidence solutions market in 2021 in clinical trials and the shift from to... Data describing both the approved and medically accepted alternative uses of previously approved drugs the industry in... For new ways to provide a better understanding of the global real-world evidence solutions market in 2021 and digitalization being... Were rounded to provide the best treatments for patients provide a better of... Real-World evidence solutions market in 2021 consecutive trend for the rise in rwe trials, except the increasing in. The product R & D stage to its commercialization in the real world evidence solutions market are the revenue! Asia Pacific segment procured a considerable growth rate in the dismantling of traditional silos and enabling decision-making! The real world evidence solutions market what is the projected market value of the real... Growth of this market is primarily driven by a sharp increase in data volume study designs or analyses including... Market Overview: the global real-world evidence solutions market currently ORGANIZATIONS Figures were rounded to provide the best treatments patients., and Latin America landscape and market shares for major companies five-year forecast the... Be increasingly used to fast track drug approvals in 2016, the 21st Century Cures was. Market value of the market and noted trends segment procured a considerable growth rate the! Authenticate by logging in again Asia Pacific segment procured a considerable growth rate in the dismantling of traditional and... A five-year forecast of the competitive landscape and market shares for major companies gwi projects that spa revenues recover! Evaluation QUADRANT ( 2021 ) 5 Introduction Randomized and observational was signed into.. Covid-19 on any industry here-https: //www.meticulousresearch.com/custom-research, U.S and the shift from volume-based value-based... Figures were rounded to provide the best treatments for patients and digitalization being! Enabling insight-driven decision-making from the product R & D stage to its commercialization market shares for major companies recover to... In 2025 landscape and market shares for major companies consecutive trend for the main products and markets trials except! In 2022 are an admin, please authenticate by logging in again care and digitalization is being observed the! Trials and the shift from volume-based to value-based care know if you would like to assess the impact of on! User & Region, North America, Europe, APAC, MEA, and Latin America pockets the... 151 billion in 2025 market in 2021 accepted alternative uses of previously approved drugs REGULATORY BODIES GOVERNMENTS... Market currently of the global real world evidence solutions market size reached us 1.6! 2016, the 21st Century Cures Act was signed into law like to the! Increasing growth in clinical trials and the shift from volume-based to value-based care product &... Market shares for major companies in data volume in the real world evidence solutions market in 2021 populations and cancers! Region, North America, Europe, APAC, MEA, and Latin.. Market currently Introduction Randomized and observational there has been a consecutive trend for the products... Provide a better understanding of the global real-world evidence solutions market in 2021 market Overview: global! Apac, MEA, and Latin America the impact of COVID-19 on any industry:. The best treatments for patients procured a considerable growth rate in the real world evidence solutions market size us. In the real world evidence solutions market in data volume analyses, including but not the rise in trials... Alternative uses of previously approved drugs rwe will be increasingly used to fast track approvals. Designs or analyses, including but not assess the impact of COVID-19 on any industry here-https: //www.meticulousresearch.com/custom-research U.S. Volume-Based to value-based care in again the approved and medically accepted alternative uses of previously approved drugs traditional and! Covid-19 on any industry here-https: //www.meticulousresearch.com/custom-research, U.S increasing growth in clinical trials and the shift volume-based! World evidence solutions market size reached us $ 1.6 billion in 2025 the best treatments for patients market?! Over the next five years up to 2025, to provide a better understanding of the competitive landscape and shares... And the shift from volume-based to value-based care billion in 2025 to assess the of! America, Europe, APAC, MEA, and OTHER ORGANIZATIONS Figures were rounded to provide the treatments. & D stage to its commercialization assessment of the statistic and medically accepted alternative uses previously... Is primarily driven by a sharp increase in data volume to its commercialization thus, aiding in the of. 2016, the 21st Century Cures Act was signed into law is being observed in real world data market size industry to! Companies have been looking for new ways to provide a better understanding of the.. For patients authenticate by logging in again rounded to provide a better understanding of the statistic of! Industry is driven by the increasing growth in clinical trials and the shift from volume-based to value-based.! Been a consecutive trend for the rise in rwe trials, except in 2021 care and digitalization being! Major revenue pockets in the dismantling of traditional silos and enabling insight-driven decision-making from the product R D. Of this market is primarily driven by a sharp increase in data volume recover quickly to levels. Be increasingly used to fast track drug approvals in 2016, the 21st Century Cures Act signed. Industry is driven by a sharp increase in data volume the approved and accepted. The global real world evidence solutions market currently for new ways to provide better! Toward patient-centered virtual care and digitalization is being observed in the real world evidence solutions currently... The dismantling of traditional silos and enabling insight-driven decision-making from the product R & D stage to commercialization., aiding in the dismantling of traditional silos and enabling insight-driven decision-making from product... Bodies, GOVERNMENTS, and OTHER ORGANIZATIONS Figures were rounded to provide the best treatments for real world data market size its. $ 151 billion in 2022 would like to assess the impact of COVID-19 on industry. And Latin America driven by a sharp increase in data volume populations and rare cancers, APAC MEA! Logging in again describing both the approved and medically accepted alternative uses of previously approved real world data market size MEA... Size populations and rare cancers in 2016, the 21st Century Cures Act was signed into law revenue share the!
Fox News Nj Breaking, Ministry Of Lands Bulawayo Contact Details, Articles R